Close
Digital Health & Ai Innovation summit 2026
Medical Taiwan 2026

VirusIQ selects the WISeKey Digital Health Passport for COVID-19 to secure digital health screening, telemedicine and diagnostic services

 VirusIQ selects the WISeKey Digital Health Passport for COVID-19 to secure digital health screening, telemedicine and diagnostic services

WISeKey International Holding, a leading cybersecurity and IoT company, signed a Strategic Collaboration Agreement with ClinIQ Inc, a healthcare incubator platform, to secure digital health screening, telemedicine and diagnostic services. ClinIQ Inc has worked with Oxford University Innovation to launch VirusIQ is a screening platform that specialises in early detection, prevention and management of virus diseases such as COVID-19. The screening platform provides private, secure and safe identity management, digital health screening, telemedicine and diagnostic services.

The collaboration with ClinIQ reinforces WISeKeyโ€™s main objective of establishing a foothold into this new segment which is projected to bring over $2 million in revenue for the Company in calendar year 2021 while at the same time it creates significant new market opportunities in the healthcare sector.

WIShelter SafePass will leverage a suite of cutting-edge eHealth secure services combining WISeID and VirusIQ platforms to ensure usersโ€™ privacy, security and safety whilst providing access to diagnostics, vaccine education and necessary medical services and data.

WISeID is a trusted identity service that enables access to the web and mobile applications with strong authentication techniques. WISeID supports online KYC onboarding, OTP and digital certificate login, and an innovative โ€œhands-freeโ€ secure login based on QR-Codes which users can read using WIShelter SafePass mobile application without even having to type any password. Additional security services include digital signature services for documents. WISeID implements standards such as OpenID Connect and OAUTH2, that can be easily integrated by customers to enhance the security of their cloud applications. WISeID can also be combined with Microsoft Active Directory, facilitating integration with corporate applications.

WISeKey, powered by VirusIQ, delivers a unique platform to governments, institutions, individuals, and transportation, sports, and entertainment companies that allows the early diagnosis and management of COVID-19 or other pandemic outbreaks. This mobile platform provides rapid access to digital health screening and individualโ€™s medical information, including COVID-19 testing and vaccination reports, digitally signed by accredited bodies, as evidence of certified immunity status. These tools will enable businesses restricted by COVID-19 to quickly reopen and rebuild.

The WIShelter Safepass suite was built by leaders in the clinical and technical field and allows for scalability and flexibility. It enables users to identify clinical COVID biomarkers, contact tracing, diagnostics, and triage for vaccine access, whilst keeping security at its core.

“The collaboration between VirusIQ and WiseKey is a testament to our common mission in keeping all citizens safe and enabling secure access to healthcare resources. Our collaboration is an important next step in bringing the world a digital health product that can be trusted to safeguard an individual’s health and identity data. We believe in improving private, secure, and safe mHealth technology that endears confidence in government, business, and community stakeholders. The future is brighter when we can work together to safely address healthcare needs,” said Dr. Ajintha Pathmanathan, CEO of ClinIQ Inc and VirusIQ Ltd.

We are proud of this strategic collaboration agreement with VirusIQ which strengthens and accelerates our strategy in the sector, by bringing technological components that meet the requirements of securing medical profiles and data while completing a coherent value proposition within the framework of a digital transformation required by the industry suffering the effects of the Covid-19 pandemic. This agreement continues the line of recent collaborations WISeKey established with Digid Diagonostics and arago,” indicated Carlos Moreno, Vice-President of WISeKey Corporate Alliances and Partnerships.

About VirusIQ
VirusIQ is a product and subsidiary of ClinIQ Inc (a healthcare incubator platform). VirusIQ Ltd was formed in January 2020 in response to the SARS-COV-2 outbreak in China with the purpose of early detection and prevention of viral outbreaks. The founder, Dr Ajintha Pathmanathan, an Anaesthesiologist and Public Health doctor with experience in treating patients during SARS-COV-1 predicted as early as January 2020 an impending pandemic with the available data and immediately commenced building a team and the platform.

About WISeKey:
WISeKey is a leading global cybersecurity company currently deploying large scale digital identity ecosystems for people and objects using Blockchain, AI and IoT respecting the Human as the Fulcrum of the Internet. WISeKey microprocessors secure the pervasive computing shaping todayโ€™s Internet of Everything. WISeKey IoT has an installed base of over 1.5 billion microchips in virtually all IoT sectors (connected cars, smart cities, drones, agricultural sensors, anti-counterfeiting, smart lighting, servers, computers, mobile phones, crypto tokens etc.). WISeKey is uniquely positioned to be at the edge of IoT as our semiconductors produce a huge amount of Big Data that, when analyzed with Artificial Intelligence (AI), can help industrial applications to predict the failure of their equipment before it happens.

Our technology is Trusted by the OISTE/WISeKeyโ€™s Swiss based cryptographic Root of Trust (โ€œRoTโ€) provides secure authentication and identification, in both physical and virtual environments, for the Internet of Things, Blockchain and Artificial Intelligence. The WISeKey RoT serves as a common trust anchor to ensure the integrity of online transactions among objects and between objects and people.

FDA Launches the Digital Health Center of Excellence

FDA Launches the Digital Health Center of Excellence

The U.S. Food and Drug Administration announced it is launching the Digital Health Center of Excellence within the Center for Devices and Radiological Health (CDRH). The launch of the Digital Health Center of Excellence is an important step in furthering the agencyโ€™s overarching dedication to the advancement of digital health technology, including mobile health devices, Software as a Medical Device (SaMD), wearables when used as a medical device, and technologies used to study medical products.

โ€œEstablishing the Digital Health Center of Excellence is part of the FDAโ€™s work to ensure that the most cutting-edge digital health technologies are rapidly developed and reviewed in the U.S.,โ€ said FDA Commissioner Stephen M. Hahn, M.D. โ€œTodayโ€™s announcement marks the next stage in applying a comprehensive approach to digital health technology to realize its full potential to empower consumers to make better-informed decisions about their own health and provide new options for facilitating prevention, early diagnosis of life-threatening diseases, and management of chronic conditions outside of traditional care settings. The Digital Health Center of Excellence will provide centralized expertise and serve as a resource for digital health technologies and policy for digital health innovators, the public, and FDA staff.โ€

The FDA will continue to build and formalize the coordinating structure and operation of the Digital Health Center of Excellence as part of an effort to modernize digital health policies and regulatory approaches, and provide efficient access to highly specialized expertise, knowledge, and tools to accelerate access to safe and effective digital health technology. The agency is appointing Bakul Patel as the first director. Bakul Patel has been leading regulatory and scientific efforts related to digital health devices at the FDA since 2010.

โ€œThe establishment of the Digital Health Center of Excellence is part of the planned evolution of the FDAโ€™s digital health program to amplify the digital health work that is already being done and building upon years of work at the agency,โ€ said Jeff Shuren, M.D., J.D., director of CDRH. โ€œIn the last several years, we have established partnerships internally and externally to coordinate digital health activities and to promote the consistency of regulatory policy while continuing to innovate in our regulatory approaches.โ€

The Digital Health Center of Excellence is primarily focused on helping both internal and external stakeholders achieve their goals of getting high quality digital health technologies to patients by providing technological advice, coordinating and supporting work being done across the FDA, advancing best practices, and reimagining digital health device oversight. Along those lines, the Digital Health Center of Excellence is creating a network of digital health experts and engaging in Collaborative Communities to share knowledge and experience concerning digital health issues and priorities with FDA staff. An integral part of the launch includes the activities that will be provided to complement advances in digital health technology โ€“ such as launching strategic initiatives that advance digital health technologies, facilitating synergies in regulatory science research in digital health, and facilitating and building strategic partnerships.

The Digital Health Center of Excellence is committed to strategically advancing science and evidence for digital health technologies within the framework of the FDAโ€™s regulatory and oversight role. While there are many aspects of the Digital Health Center of Excellence that are still under development, ultimately the goal is to empower digital health stakeholders to advance health care by fostering responsible and high-quality digital health innovation.

The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nationโ€™s food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.

Tampa General Hospital announces strategic partnership with Philips to innovate and improve patient experience

Tampa General Hospital announces strategic partnership with Philips to innovate and improve patient experience

Tampa General Hospital (TGH) and Royal Philips, a global leader in health technology, announced they are creating a long-term strategic partnership designed to keep Tampa General Hospital at the forefront of technological innovation.

Tampa General, one of the largest hospitals in the U.S., will have early and ongoing access to the latest Philips innovations during the seven-year arrangement. This will allow the hospital to continue delivering world-class care while lowering costs.

โ€œWe are humbled by the heroic work the TGH team is doing during the pandemic and their dedication to constantly improving care across the board, even in these difficult times,โ€ said Vitor Rocha, Chief Philips North America, member of the Executive Committee Royal Philips. โ€œThe relationship between TGH and Philips builds on a shared drive for innovation in healthcare โ€“ to deliver on the Quadruple Aim, break down the barriers between hospital and home and improve peopleโ€™s lives. For us, the partnership is more than transactional. It means taking the time to truly understand their patientsโ€™ needs and suggest solutions that can address their workflow and service line needs today, while planning for tomorrow.โ€

Under the terms of this strategic partnership, Philips will provide the hospital with millions of dollarsโ€™ worth of new solutions such as new software packages, healthcare informatics, unique workflow solutions and high-level consulting.

As a result, Tampa General will replace all bedside patient and vital sign monitors throughout the 1,006-bed hospital and upgrade key imaging equipment in the catheterization laboratories and interventional radiology rooms.

Philips also plans to deliver a standardized platform, providing doctors and clinicians with a better overall view of the patient to help make the best decisions when it comes to diagnosis and providing world-class care.

โ€œThis partnership allows us to stay on the leading edge of technology for many years to come, in a cost-effective way,โ€ said TGH President and CEO John Couris. โ€œPhilips not only provides new solutions, but also serves as a valuable partner by helping us improve our workflows and optimization. Tampa Generalโ€™s vision is to become the safest and most innovative academic health system in America, and long-term commitments like this one will help us achieve that vision.โ€

The transformational partnership shows Tampa General is investing in long-term innovation. Together, Philips and Tampa General have already invested more than 1,000 hours on technology replacement planning and performed over 400 clinical staff interviews to understand how to better improve the patient and staff experience.

Philips is also working on a technology replacement plan which includes implementing cloud-based technologies such as Philips PerformanceBridge. This technology gives users a view to all their diagnostic equipment and ensures that TGH gets the latest in medical innovation in a cost-effective, timely way.

A key benefit for Tampa General is that Philips solutions are built to integrate with the hospitalโ€™s existing technologies for a seamless experience for clinicians and patients.

About Royal Philips

Royal Philips is a leading health technology company focused on improving people’s health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2019 sales of EUR 19.5 billion and employs approximately 81,000 employees with sales and services in more than 100 countries.

 

Philips expands peripheral vascular disease portfolio with the QuickClear mechanical thrombectomy system for blood clot removal

 Philips expands peripheral vascular disease portfolio with the QuickClear mechanical thrombectomy system for blood clot removal

Royal Philips, a global leader in health technology, today announced the launch of the innovative QuickClear mechanical thrombectomy system. The compact, single-use system provides an all-in-one aspiration pump and catheter for the removal of blood clots from the vessels of the peripheral arterial and venous systems. The systemโ€™s innovative all-in-one design is simple to use while eliminating the need for capital equipment or costly accessories, with easy setup supporting faster procedures times. The Philips QuickClear Mechanical Thrombectomy System has received U.S. FDA 510(k) clearance and is available for sale in the U.S.

โ€œThis novel thrombectomy system is the latest addition to Philipsโ€™ market-leading portfolio for the diagnosis and treatment of peripheral vascular diseases,โ€ said Chris Landon, Senior Vice President and General Manager Image Guided Therapy Devices at Philips. โ€œIts intuitive design simplifies the entire thrombectomy procedure workflow. By taking away the high initial capital expenditure costs associated with traditional mechanical thrombectomy systems, QuickClear can help bring cost-effective solutions to both the hospital and outpatient care settings.โ€

Simple, optimized performance

QuickClear simplifies the entire thrombectomy procedure workflow. The small footprint of the sterile device allows it to be placed easily and conveniently on the table next to the patient. With the touch of a button, the system is up and running at maximum aspiration power within seconds. The consistency of the aspiration power during the procedure provides physicians more control and supports faster procedure times. The systemโ€™s range of catheters includes a large 10F aspiration catheter, providing 59% more aspiration volume than 8F aspiration catheters.

โ€œQuickClear is a simple and easy to use mechanical thrombectomy system,โ€ said Bryan Fisher, MD, Chief of Vascular Surgery, Tristar Centennial Medical Center, Nashville, U.S. โ€œThe system is significantly smaller than other systems without compromising aspiration power. The convenience of the device really shines through with its single use and lack of capital equipment. I am excited about the potential of this device and the impact it will have on my practice and the patients I treat.โ€

Philipsโ€™ peripheral vascular portfolio already includes advanced interventional imaging systems for precision guidance; intravascular ultrasound (IVUS) catheters to assess the location of the disease and lesion morphology and guide and confirm the treatment; peripheral atherectomy devices to remove blockages; and peripheral therapy devices, such as Philipsโ€™ Stellarex drug-coated balloon, to treat lesions. Philips recently further extended this portfolio with the acquisition of Intact Vascular, maker of the Tack Endovascular System, a first-of-its-kind, minimal-metal, dissection repair device that provides precision treatment of peripheral arterial dissections following balloon angioplasty in above-the-knee (ATK) and below-the-knee (BTK) therapeutic interventions.

New Cardiovascular Horizons digital symposium

Today, September 24th at 19:00 ET Philips will host a symposium entitled โ€˜QuickClear Mechanical Thrombectomy System: A Powerfully Simple and Cost-Effective Solutionโ€™ as part of the New Cardiovascular Horizons (NCVH) digital education series. To register, visit here.

The Philips QuickClear Mechanical Thrombectomy System is U.S. FDA 510(k) cleared and available for sale in the U.S., with future expansion of availability to other geographies planned

About Royal Philips

Royal Philips is a leading health technology company focused on improving people’s health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2019 sales of EUR 19.5 billion and employs approximately 81,000 employees with sales and services in more than 100 countries.

IDSolutions and Tryten Announce Expanded Telehealth Solutions to Support Hospital Virtual Care

IDSolutions and Tryten Announce Expanded Telehealth Solutions to Support Hospital Virtual Care

IDSolutions (IDS), end-to-end telehealth solution provider, and Tryten, manufacturer of healthcare and education carts, announced they are expanding their joint solution offering in healthcare.

IDS first teamed up with Tryten in 2018 during the creation of MedSitter, their second-generation remote patient observation solution. MedSitter’s hardware and patent-pending software applications are deployed on Tryten’s Nova Tall medical carts.

As the Covid-19 pandemic continues to unfold, the two companies agreed to expand their combined offering to support additional telemedicine use cases: Virtual Visitations, Video Intercom, and Virtual Rounding. By incorporating Tryten’s cart with IDS’ hardware + software integration capabilities, the organizations are ensuring their customers obtain every ounce of value from their hardware investment.

Given all the stressors that have been placed on our healthcare system in the last 8 months, it is critical to make solutions available that are not only safe, flexible and affordable, but are easy to implement, support and use,” says Dr. Deb Jeffries, Global Director of Healthcare for Tryten. “Tryten is proud to be working with IDSolutions so that together we can deliver solutions that truly meet the needs of healthcare systems and help them provide safe care when and where it is needed.”

“We recognize that the telehealth equipment healthcare organizations need for virtual care depend on the specialties they serve,” says Nicholas Luthy, VP of Products at IDS. “Our purpose-built solutions are engineered to be simple, versatile, and clinical. Product offerings range from a lightweight frame with a tablet, to ergonomic carts that accommodate multiple medical grade accessories.”

IDS and Tryten Telehealth Solutions Include:

1. Hardware + Software โ€“ Tryten carts are designed and pre-configured with the necessary equipment to run HIPAA compliant video conferencing software or MedSitter, IDS’ cloud-based virtual patient observation solution.

2. Professional Services โ€“ a broad portfolio of value-added services is included from consulting, workflow design, engineering, project management, clinical education, and staff training.

3. Contactless Implementation โ€“ through the Rapid Response Implementationโ„ข Program, carts arrive fully-assembled and roll-out ready.

4. 24/7/365 Support & Managed Services โ€“ IDS’ Platinum Plus support plan provides technical assistance from the IDS Customer Care team including proactive network monitoring, advanced parts replacement, software maintenance & upgrades, and help desk services.

“Our team continues to go above and beyond to respond to the needs of our customers,” says IDS Founder and President, Tracy Mills. “Partnering with Tryten to leverage their industry leading cart is an obvious choice. Tryten’s versatile design is key to delivering solutions that provide our customers new ways to generate value with the same equipment.”

“At Tryten, we are passionate about helping others. Extending the number of ways we can help enable better care and patient outcomes is top of mind. By working with IDSolutions, we are able to help bring high quality turn-key solutions to healthcare providers and ultimately more timely care to patients for better outcomes,” says Tony Jansen, Founder and CEO of Tryten.

How to Make an Online Pharmacy a Success

How to Make an Online Pharmacy a Success

Businesses are moving towards the online world, especially with the recent pandemic and the lockdown that it brought. There is potential for huge amounts of earnings, but if it is not handled well, you can quickly watch your business crumble. It might surprise people, but online pharmacies are becoming a thing, with patients getting their medications online. If you are planning on running an online pharmacy business, here is how you can make it a success.

Endorsements From Medical Sites

There are plenty of medical sites out there that talk about prescriptions and illnesses. People often turn to these websites for advice and help on what they should do. A great way to make sure your pharmacy is a success is to get on the online directory of one of these websites. They generate plenty of traffic which means that plenty of people will be seeing your pharmacy daily.

How can you go about getting onto these directories? Simply get in touch with them and tell them about your business. They will take some time to deem if you are reputable or not. Once they have done so, they will come up with a plan on how to get you listed on their website. This will often include a fee or a monthly payment but it is well worth the investment to guarantee the success of your pharmacy.

Endorsements From Doctors

People are wary of buying drugs and medicines online. Even though it comes with a tamper-proof seal, people question if they have received the correct medication or if it was altered in any way. One of the ways to combat this is to get in touch with doctors and get their approval and patients.

Doctors are the ones who hand out prescriptions that have to be filled by the pharmacy. By talking to a doctor, you could possibly convince them to use your website as their pharmacy for their patients. With their doctor endorsing it, patients will be that much more likely to use your website and acquire their medications from it.

Donโ€™t just stop at one or two doctors either. The more doctors that you can get to give you an endorsement means the more patients and prescriptions that you will have to fill. Some doctors will ask for a cut or a fee for choosing you so it becomes a game of whether or not it is worth it. The more doctors that you can get on board with your pharmacy, the more success you are going to have.


Search Engine Optimization

With any business, the more people who see it, the better the chances of you making a sale. Search engine optimization or SEO is a tool employed by many companies that allows them to show up much sooner in search engines when keywords are searched. When a website is first created, it does not rank, meaning it will not show up in a search engine.

Taking the necessary steps and hiring a company to boost you will result in great things for your business. It will allow you to rank on search engines while also exponentially increasing the number of people who view your site. Typically speaking in the medical world, people who go to online pharmacies are looking to purchase right away, not shop around for what is available. Therefore, the more people you can attract over to your website, the more successful you will be.

Offer Slightly Lower Prices

Medicine and drug prices are already incredibly escalated for anyone needing them. If you want to build a reliable customer base and find success, you are going to have to find a way to steal customers from regular pharmacies. The best way you can do this is by offering prices that are lower than your competitors.

When people see this, they will be much more willing to give you a try and order a prescription or two. They can save money and not even have to worry about leaving the house. Do you really want to leave the house to get medicine if you are sick?

Another thing to consider is providing free shipping to your customers. Shipping costs often scare people away and cause them to stick to physical retail places. By offering free shipping, you can get away from all of that and keep your customers interested in your pharmacy.

By using all of these tips, you are sure to get your pharmacy the exposure and success that it needs to run. Remember to be patient as starting a business does take time and getting a reliable customer base can take even longer. Stick with it and do your best to stay in touch with the medical world. When do you plan on opening your pharmacy?

B-LiFE deploys a mobile laboratory in the Piedmont Region of Italy to carry out COVID-19 tests with the support of ETELM

B-LiFE deploys a mobile laboratory in the Piedmont Region of Italy to carry out COVID-19 tests with the support of ETELM

As one of the most severely affected places by COVID-19, the Government of the Piedmont Region in Italy requested that the B-LiFE (Biological Light Field Laboratory for Emergencies) service was deployed in the area since June to carry out vital COVID-19 diagnostic tests. Using its advanced mobile laboratory,the mission of the B-LiFE department was to carry out a large number of COVID-19 tests for first responders, civil protection, health personnel, police and volunteers.

The deployment of B-LiFE is led by the Centre for Applied Molecular Technologies of UCLouvain (Catholic University of Louvain) with the support of ESA (European Space Agency), the Luxembourg Government and its Ministry of Defence. B-LiFE’s partners in this humanitarian mission are Belgian companies Eonix and NazkaMapps, Luxembourgcompaniesโ€™ SES and GovSat, and French company ETELM.

B-LiFE was developed as part of the ESA Space Solutions programme (formerly known as IAP-ARTES 20), with the participation of Belgium and Luxembourg. The integration of satellite and terrestrial telecommunications, information management, earth observation, location management and real-time epidemiological mapping allows B-LiFE to be deployed very quickly, autonomously and as close as possible to a crisis zone.

Mobile laboratories have become extremely important during the COVID-19 pandemic. B-LiFE is one of the most advanced mobile laboratories in the world and has been operational since 2014 when it was successfully deployed in Guinea during the Ebola outbreak. It is integrated and certified in the European Civil Protection Mechanism (EUCPM).

ETELM, a partner of B-LiFE, has made a critical contribution to the initiative in supplying telecommunications services. It has enabled the integration of TETRA and LTE terrestrial telecommunications capabilities into the satellite terminal provided by SES, GovSat and the Luxembourg Ministry of Defence. This work was necessary to ensure full autonomy during acrisis situation and to enable interoperability with local emergency services.

ETELM’s 4GLinked Unified Mobile Platform has been successfully deployed and tested to support B-LiFE laboratory operations, including PMR TETRA and LTE base stations. ETELM’s participation in the B-LiFE mission in the Piedmont Region, and the successful use of its equipment and service,ensures the companyโ€™s ongoing partnership with B-LiFE.

About ETELM
ETELM is a French SME with a core expertise and a solid experience in providing innovative end-to-end Mission and Business Critical Radio Communications solutions.

ETELM has been designing, developing and manufacturing radio infrastructure for private fixed and tactical networks (PMR, TETRA and lately Mission Critical LTE) for more than 40 years. ETELM has developed an innovative 4GLinked solution that helps to seamlessly interconnect TETRA and LTE radio infrastructures into a single unified network for a smooth transition from narrowband to broadband communications. The 4GLinked concept can be applied to other technologies such as, for example, DMR. ETELM also specialises in Critical Communications Portable and In-vehicle Solutions that are quick and easy to deploy and enable users on the field to communicate efficiently across different technologies (4G, TETRA and Hybrid 4G+TETRA).

As a developer and manufacturer, ETELM invests continuously in the R&D activities and has the flexibility to provide tailored solutions in conformity with the ETSI/3GPP standards. ETELM works for Mission and Business Critical users that need secure and reliable communications.

RHON-KLINIKUM Campus Bad Neustadt becomes Center of Reference for cardiovascular medicine

RHON-KLINIKUM Campus Bad Neustadt becomes Center of Reference for cardiovascular medicine

RHร–N-KLINIKUM AG and Siemens Healthineers have signed a partnership agreement under which RHร–N-KLINIKUM Campus Bad Neustadt acquires the status of Siemens Healthineers European Center of Reference for Cardiovascular Medicine. This gives both national and international customers of Siemens Healthineers the opportunity to learn from the medical experts in Bad Neustadt how state-of-the-art imaging systems and solutions can be used more efficiently in diagnostics, therapy, and aftercare for patients with cardiovascular diseases.

The certificate will be awarded during the internal event โ€œNetworking and interaction between cardiology, heart surgery, radiology, and rehabilitationโ€ at the RHร–N-KLINIKUM Campus Bad Neustadt on September 24.

Multi-sector collaboration for the patientโ€™s benefit

Being named as an international Center of Reference for cardiovascular medicine is just one acknowledgment of the hospitalโ€™s approach to integrating treatment for heart-failure patients across medical specializations. In May 2020, the project โ€œTrans-sectoral treatment according to requirements of patients with cardiac insufficiency and development of an alternative remuneration modelโ€ (โ€œsekTOR-HFโ€), initiated by RHร–N-KLINIKUM AG, also received a project grant for a total of 42 months from the Innovations Committee in the Federal Joint Committee (G-BA).

sekTOR-HF is a collaborative project between medical and scientific partners in the focal regions of Rhรถn-Grabfeld (Bavaria) and Marburg-Biedenkopf (Hesse). โ€œWe developed this project on the basis of our RHร–N Campus concept, which has enabled us to provide multi-sector healthcare for our patients for a number of years, including the use of digital networking,โ€ explains Professor Bernd Griewing, Member of the Managing Board of RHร–N-KLINIKUM AG. โ€œWith sekTOR-HF, weโ€™re aiming to break down real-world sector boundaries and be able to think and work as part of regional networks. Otherwise the system simply wonโ€™t work in the future, especially in rural regions.โ€ Professor Sebastian Kerber, head of Cardiology I at RHร–N-KLINIKUM Campus Bad Neustadt, adds: โ€œThere are particular challenges associated with handling, diagnosing, and treating patients with heart failure. Only differential diagnosis and personalized heart-failure therapy can enable reasonably lengthy survival times and improve quality of life.โ€

Long-term cooperation

โ€œMany years of highly successful cooperation link us with RHร–N-KLINIKUM Campus Bad Neustadt,โ€ observes Dr. Bernd Ohnesorge, head of the Europe, Middle East and Africa (EMEA) Region at Siemens Healthineers. โ€œFor example, we helped the hospital to successfully integrate multimodal therapy concepts in diagnostic imaging and image-guided therapy into its clinical routine. In the future, weโ€™ll also function as a full strategic partner to RHร–N-KLINIKUM Campus Bad Neustadt to develop innovative models to bolster healthcare at a regional level. All of this confirms my view that RHร–N-KLINIKUM Campus Bad Neustadt is ideally suited to be a European Center of Reference for cardiovascular medicine.โ€

The experts in cardiovascular care at Siemens Healthineers view themselves mainly as advisers who offer end-to-end solutions intended to help restructure healthcare in cardiovascular medicine. Their guiding principles are the expansion of precision medicine, improving the patient experience, and digitalization of the healthcare sector.

โ€œFor me, the crucial factor is that Siemens Healthineers not only manufactures devices, they also help us develop innovations perfectly suited to ensuring the best possible diagnostic and treatment workflows at our hospital,โ€ says Dr. Lukas Lehmkuhl, head of Diagnostic Radiology at RHร–N-KLINIKUM Campus Bad Neustadt. โ€œWeโ€™re looking forward to being able to welcome internationally renowned cardiologists, radiologists, and surgeons to our facility to show them our approach and our innovations.โ€

โ€œRHร–N-KLINIKUM Campus Bad Neustadt provides comprehensive care for patients with cardiovascular diseases and pursues an integral treatment strategy covering the entire clinical patient pathway,โ€ says Doris Pommi, General Manager Global Cardiovascular Care at Siemens Healthineers. โ€œThat makes this hospital especially well-suited to serve as a reference site for cardiovascular solutions. Integrated innovations and concepts that optimize patient therapy in order to achieve better treatment results are our common goals.โ€

History of successful collaboration between Siemens Healthineers and RHร–N-KLINIKUM Campus Bad Neustadt

Clinical and scientific collaboration with RHร–N-KLINIKUM Campus Bad Neustadt began as early as 2001 with the efficient integration of various methods of cardiovascular imaging in order to improve diagnostics and image-guided therapy in cardiovascular healthcare. In addition, imaging and therapeutic intervention became increasingly closely linked with the refinement of the clinical pathway concept, thanks to the integration of diagnostic imaging modalities. Radiology and interventional cardiology grew together to form a multimodal pathway concept for patient-centered imaging. โ€œNow, with more than 1,500 MRI and about 600 to 800 CT scans each year in cardiac diagnostics alone, RHร–N-KLINIKUM Campus Bad Neustadt has been one of the first users of this multimodal concept,โ€ says Professor Thomas Deneke, head of Cardiology II at RHร–N-KLINIKUM Campus Bad Neustadt.

In 2010, Siemens Healthineers and RHร–N-KLINIKUM Campus Bad Neustadt worked together successfully on extensive consulting approaches to systematically assess and improve hospital operation and on clinical processes to improve results for selected diseases. At the time, RHร–N-KLINIKUM Campus Bad Neustadt provided elements of best practices for the standardized management of acute coronary syndrome (ACS) and heart failure โ€“ for example, the CardioAngel project โ€“ and established one of the first special wards for patients in the advanced stages of heart failure.

Fields for future collaboration

Both partners want to continue to encourage the sharing of knowledge and experience in cardiology in the future. One example is a clinical training program for physicians and the medical assistance professions. In the future, they hope to work together to improve clinical workflows and continue to develop innovative treatment strategies for non-invasive and invasive cardiology. This will include defining diagnostic and treatment pathways that will make patient care even more efficient and personalized. In direct interaction with various Siemens Healthineers Business Areas, RHร–N-KLINIKUM Campus Bad Neustadt will also support the development of future processes and technologies. Their shared insights will flow into future developments from Siemens Healthineers.

About RHร–N-KLINIKUM Campus Bad Neustadt
RHร–N-KLINIKUM Campus Bad Neustadt, one of five locations operated by RHร–N-KLINIKUM AG, provides multi-sector medical care in rural areas. At its hospital premises,the campus brings together outpatient and inpatient services with a wealth of medical and preventive care services that werenโ€™t previously co-located: Self-employed specialists and clinics representing diverse fields like cardiac medicine, orthopedic surgery, and neurology work hand-in-hand with nursing and rehabilitation services. An essential element in this setting is the digital networking of all the players involved in the treatment process using innovative IT solutions and communication systems. The more than 2,800 employees at the campus treat about 78,000 patients every year.

About Siemens Healthineers
Siemens Healthineers enables healthcare providers worldwide to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, improving patient experience and digitalizing healthcare. A leader in medical technology, Siemens Healthineers is constantly innovating its portfolio of products and services in its core areas of diagnostic and therapeutic imaging and in laboratory diagnostics and molecular medicine. Siemens Healthineers is also actively developing its digital health services and enterprise services.

In fiscal 2018, which ended on September 30, 2018, Siemens Healthineers generated revenue of โ‚ฌ13.4 billion and adjusted profit of โ‚ฌ2.3 billion and has about 50,000 employees worldwide.

.

How do you write a slip and fall incident report?

How do you write a slip and fall incident report?

Slip and fall accidents can occur relatively anywhere. As a product of the environment and the lack of oneโ€™s own personal awareness, slip and fall accidents might infer that their only liability is yourself, but that is often not the case. When you are visiting an area or a private property maintained by someone else, you may be able to seek injury compensation in response to their failure to maintain a safe environment if an accident has occurred. A premises liability claim can then be issued against the property owner, landlord, or figure of authority to accurately compensate for lost workdays and high medical costs. If you wish to prove and hold someone at fault, you need to write a slip and fall incident report. If you are looking to defend your claim in the court of law, consider Fresno Slip and Fall Accident Lawyers.

A slip and fall incident report includes all the necessary information about your accident. It is a mandatory report needed to facilitate the ability of compensation for your injuries.

Report framework

Before you contact an attorney, it is crucial that you have a proper outline detailing the incident that you can use for reference. It is easy to find fault in a slip and fall case, but backing it up with evidence requires that you recount and note the details of the incident as quickly as possible so that crucial factual items of note are not forgotten. Finding a report outline example online is quite easy โ€“ you should choose one that relates best to your situation, and add to it depending on the complexity of the case. Make sure to consider the statute of limitations if you wish to file a lawsuit or receive injury compensation. Act fast contact the property owner or person in charge of the maintenance to see if the issue can be rectified in a civil manner.

Alternatively, if you have suffered from an injury in a business location, the Occupational Safety and Health Administration (OSHA) necessitates that all businesses require proper slip and fall incident reports that you can fill out at the ready. While this makes the incident report much more accessible, it is, however, still essential that the incident is reported to an attorney if you wish to seek proper legal action.

Content and prerequisites

Slip and fall cases are in no way a jovial manner. They comprise over 8 million hospital visits annually, totaling to one in five of every annual hospital visit. Slip and fall cases are a question of when, not if. Their severity increases exponentially by age, and are the leading cause of missed workdays.

When writing a slip and fall report:

  • Recount the details of the incident (date, time, location, activity in question, cause of fall, etc.);
  • Inspect the location of the fall, including environmental conditions and any other special circumstances involving the accident;
  • Retrieve evidence of injuries (photos, hospital reports, etc.), including medical expenses, income losses, and other incidents of suffering;
  • Inform witnesses, follow up on their narrative;

These are the main details of a slip and fall incident report, but your attorney may ask for you to provide additional information depending on the circumstance of the accident. For example, is important to note whether you were visiting the property or area in question legally, and were allowed to be there in the first place.

Most importantly, you should remember that a slip and fall case is necessary to be resolved so that the environment is better prepared and safer for other people and that your injuries are fairly compensated for by the person at fault of the accident.

Precision Textiles make PPE manufacturing permanent part of its product portfolio

Precision Textiles make PPE manufacturing permanent part of its product portfolio

Six months ago, when Precision Textiles put a toe in the water to try its hand at producing personal protective equipment (PPE), the strategy was designed to keep its plant open and employees working. But the strategy has been so successful, that the leading supplier of coated fabrics, nonwovens and laminations for the bedding, automotive, healthcare and home furnishings industries has now purchased additional manufacturing equipment to make the PPE line a permanent part of its product portfolio.

With the addition of six new laminating machines dedicated to producing medical gown fabric, Precision Textiles can now produce an additional 1.5 million yards of domestically-sourced fabric each month. These additional machines have allowed the company to hire 25 new machine line operators and supervisors that will solely produce medical gown fabric.

โ€œWhen the coronavirus pandemic erupted, we began manufacturing medical gown and mask fabrics in order for us to remain an essential business. We saw what our country needed, and we were able to respond quickly to this demand. We see now that PPE materials made domestically and are readily available to meet the needs of our customers are more important than ever, and we look forward to further expanding into this category,โ€ said Scott Tesser, chief executive officer of Precision Textiles.

During the initial outbreak, Precision Textilesโ€™ 210,000-square-foot manufacturing facility became an essential business providing more than 28 million yards of PPE to hospitals, businesses and non-profit organizations to-date. Along with production, which was completed in the New Jersey factory, all the polyester staple film, TPU fiber and other materials used to make the fabrics were sourced domestically.

To continue making PPE domestically, Precision Textiles is committed to sourcing the necessary materials state-side, as well as bringing all PPE production to its U.S. facilities. This move will also create numerous of jobs within the industry.

โ€œOver the course of my career, I watched how garment production slowly made its way overseas and never came back,โ€ Tesser said. โ€œI started in this business straight out of college; my father was in the apparel industry and my grandfather before him. I remember the days of garment racks being pushed down the streets and cutting rooms full of hustle. To me, it was what our country was built on. Hard work and labor. We were a country that made things.

โ€œI was proud to be a part of that, and itโ€™s time to bring manufacturing back to the United States. I donโ€™t want to see our nationโ€™s reliance on PPE in the hands of foreign manufacturers. We can and we will make it here,โ€ he added.

Founded in 1987, Totowa, New Jersey-based Precision Textiles is a global supplier of coated fabrics, nonwovens and laminates for companies in the mattress, home furnishings, automotive and health care industries, as well as military apparel. With a specialized emphasis on flame retardant compliant materials designed for use in mattresses and sleep products, the company manufactures its family of products at its 210,000-square-foot headquarters that includes a state-of-the-art laboratory, factory and warehouse. The company also holds four additional warehouses strategically located in the U.S., as well as two warehouses in Asia.

Translate ยป